Future LRMN Events
LRMN & PeproTech
The LRMN is working together again with PeproTech to hold an event in early 2016.
PeproTech is a privately owned biotechnology company focusing on the development and manufacture of high quality cytokine products for the life-science and cell therapy market. Over the past 25 years the company has grown into a global enterprise with state-of-the-art manufacturing facilities in the US, and offices around the world.
LRMN & Thermo Scientific
The LRMN is working together again with Thermo Scientific to hold an event in early 2016.
Thermo Scientific bioproduction products offer single-use solutions that enable vaccine and cell therapeutic producers to rapidly respond to manufacturing demands. The portfolio of single-source solutions optimises process efficiency, expediting product development and market introduction. Thermo’s proven products and services are specifically designed to support upstream or downstream processing needs.
LRMN & Miltenyi Biotec
The LRMN is working together again with Miltenyi Biotec to hold another event in Spring 2016.
Miltenyi Biotec lead the field in designing and manufacturing products and services to advance biomedical research and cellular therapy. Specifically, Miltenyi's innovative GMP Cell Processing Platform (the CliniMACS Prodigy), GMP Raw Materials and GMP Lentiviral Vector production provide a unique solution in manufacturing CAR and TCR T Cell products for therapy. Closed-system and automated, simple tech transfer and easy scale out. Isolation, transduction, expansion and final formulation in one end-to-end device, supporting cell therapy now and towards its future.
More information on all our future events, including a finalised date and the programme, will be given in due course, with invitations sent out to the LRMN mailing list as usual.